Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant DMPA in Endometrial Cancer/Hyperplasia
NCT02335203Phase 2Unknown
- Sponsor
- Women & Infants Hospital
- Start
- Feb 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of medroxyprogesterone acetate in endometrial adenocarcinoma, complex atypical endometrial hyperplasia (EIN), sponsored by Women & Infants Hospital. Status: unknown.
02
Drugs
medroxyprogesterone acetate
03
Conditions
endometrial adenocarcinomacomplex atypical endometrial hyperplasia (EIN)
Beyond the preview
Go deeper on NCT02335203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02335203.